^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Endometrial Cancer
    Drug:gemcitabine (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    09/20/2023
    Excerpt:
    Endometrial Carcinoma: SYSTEMIC THERAPY FOR ENDOMETRIAL CARCINOMA…Other Recommended Regimens…Gemcitabine…